183
Views
1
CrossRef citations to date
0
Altmetric
Reports

Very late recurrence of B-cell acute lymphoblastic leukemia masquerading as a pituitary tumor

, , , , , , & ORCID Icon show all
Pages 438-444 | Received 22 Jan 2020, Accepted 30 Mar 2020, Published online: 16 Apr 2020

References

  • Tilley E, Ryalls MR, Williams MP. CT demonstration of pituitary stalk relapse in childhood acute lymphoblastic leukaemia. Clin Radiol. 1989;40(6):634–635. doi:10.1016/S0009-9260(89)80330-7.
  • Hon C, Law RW, Shek TW, Au WY. CNS manifestations of malignancies: case 1. Conjunctival relapse of acute lymphoblastic leukemia heralding pituitary and CNS disease. JCO. 2005;23(18):4225–4226. doi:10.1200/JCO.2005.04.133.
  • Yanagisawa R, Nakazawa Y, Sakashita K, et al. Intrathecal donor lymphocyte infusion for isolated leukemia relapse in the central nervous system following allogeneic stem cell transplantation: a case report and literature review. Int J Hematol. 2016;103(1):107–111. doi:10.1007/s12185-015-1902-1.
  • Petersenn S. Biochemical diagnosis in prolactinomas: some caveats. Pituitary. 2020;23(1):9–15. doi:10.1007/s11102-019-01024-z.
  • Surapaneni UR, Cortes JE, Thomas D, et al. Central nervous system relapse in adults with acute lymphoblastic leukemia. Cancer. 2002;94(3):773–779. doi:10.1002/cncr.10265.
  • Pui CH. Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. Hematology Am Soc Hematol Educ Program. 2006;2006(1):142–146. doi:10.1182/asheducation-2006.1.142.
  • Pui CH. Acute lymphoblastic leukemia in children. Curr Opin Oncol. 2000;12(1):3–12. doi:10.1097/00001622-200001000-00002.
  • Cortes J, O'Brien SM, Pierce S, Keating MJ, Freireich EJ, Kantarjian HM. The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia. Blood. 1995;86(6):2091–2097. doi:10.1182/blood.V86.6.2091.bloodjournal8662091.
  • Nemoto K, Ohnishi Y, Tsukada T. Chronic lymphocytic leukemia showing pituitary tumor with massive leukemic cell infiltration, and special reference to clinicopathological findings of CLL. Acta Pathol Jpn. 1978;28(5):797–805. doi:10.1111/j.1440-1827.1978.tb00918.x.
  • Rye AD, Stitson RN, Dyer MJ. Pituitary infiltration in B-cell chronic lymphocytic leukaemia. Br J Haematol. 2001;115(4):718–718. doi:10.1046/j.1365-2141.2001.03210.x.
  • Fain JS, Naeim F, Becker DP, et al. Chronic lymphocytic leukemia presenting as a pituitary mass lesion. Can j Neurol Sci. 1992;19(2):239–242. doi:10.1017/S0317167100042335.
  • Romeike BF, Joellenbeck B, Stein H, et al. Precursor T-lymphoblastic lymphoma within a recurrent pituitary adenoma. Acta Neurochir (Wien)). 2008;150(8):833–836. doi:10.1007/s00701-008-1585-y.
  • Lin HW, Shih SR, Yao M, Huang TS. Relapse of acute myeloid leukemia at the pituitary gland: a case report and review of literature. Endocr Pathol. 2012;23(3):172–176. doi:10.1007/s12022-012-9203-1.
  • Fleischmann T, Hilgendorf I, Franiel T. Das Myelosarkom der Hypophyse – eine Rarität eines isolierten Rezidivs einer akuten myeloischen Leukämie. Fortschr Röntgenstr. 2018;190(03):273–274. doi:10.1055/s-0043-122080.
  • Novello M, Coli A, Della Pepa GM, et al. Myeloid sarcoma with megakaryoblastic differentiation mimicking a sellar tumor. Neuropathology. 2014;34(2):179–184. doi:10.1111/neup.12071.
  • Ford AM, Fasching K, Panzer-GrüMayer ER, Koenig M, Haas OA, Greaves MF. Origins of “late” relapse in childhood acute lymphoblastic leukemia with TEL-AML1 fusion genes. Blood. 2001;98((3):558–564. doi:10.1182/blood.V98.3.558.
  • Sautner D, Saeger W, Ludecke DK. Tumors of the sellar region mimicking pituitary adenomas. Exp Clin Endocrinol Diabetes. 2009;101(5):283–289. doi:10.1055/s-0029-1211245.
  • Valassi E, Biller BM, Klibanski A, Swearingen B. Clinical features of nonpituitary sellar lesions in a large surgical series. Clin Endocrinol (Oxf). 2010;73(6):798–807. doi:10.1111/j.1365-2265.2010.03881.x.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.